Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy
NCT03166904
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Lack of efficacy
Conditions
Solid Tumor
Interventions
DRUG:
Vistusertib(AZD2014)
Sponsor
Samsung Medical Center